Position in MYGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$464,748
New position
Shares Held
81,392
first reported quarter
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 195 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ZACKS INVESTMENT MANAGEMENT holds $85,439,394 across 8 Diagnostics & Research names. MYGN ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
158,423 | $30,176,413 | |
| 2 | LH |
Labcorp Holdings Inc.
|
85,568 | $23,959,040 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
43,021 | $21,569,008 | |
| 4 | ILMN |
Illumina, Inc.
|
28,137 | $4,947,328 | |
| 5 | VCYT |
Veracyte, Inc.
|
62,229 | $3,654,709 | |
| 6 | MYGN |
Myriad Genetics Inc
This page
|
81,392 | $464,748 | |
| 7 | A |
Agilent Technologies, Inc.
|
3,494 | $464,108 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,056 | $204,040 |
All Filings in MYGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $464,748 | 81,392 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||